Close Menu

Personalis

This article has been updated to reflect the increased size of a study by Inova.

Personalis has hired Deanna Church to the position of senior director of genomics and content.

Kevin Shianna has left the New York Genome Center, where he was most recently deputy scientific director of sequencing operations.

Personalis has launched an early-access program for its "Accuracy and Content Enhanced," or ACE, Clinical Exome test to diagnose rare Mendelian disorders, which it hopes will increase the diagnostic yield of conventional diagnostic exome sequencing.

Illumina has launched its TruGenome tests, including ones for undiagnosed disease and a predisposition screen as services through its CLIA-certified and CAP-accredited laboratory.

NEW YORK (GenomeWeb News) – Next-generation sequencing and interpretation provider Personalis has closed a $22 million Series B financing round, the company said today, bringing total investments in the firm to more than $42 million.

Personalis, provider of genetic sequencing and data interpretation to researchers and clinicians, this week formed a UK subsidiary and appointed Mark Dronsfield as the director of European sales.

Sanford-Burnham Medical Research Institute has elected Gregory Lucier to chairman of the board. He will take over from M. Wainwright Fishburn Jr., who will remain a member of the board.

NEW YORK (GenomeWeb News) – Personalis has formed a UK subsidiary, Personalis UK Limited, to serve its customers in Europe.
Menlo Park, Calif.-based Personalis provides researchers and clinicians human DNA sequencing and interpretation services.

Pages

The Centers for Disease Control and Prevention estimates more people get sick and die from drug-resistant germs than previously thought, the Washington Post reports.

According to the Associated Press, three universities and a healthcare institution are sharing a gift of $1 billion.

New rules seek to limit the type of scientific and medical research that can be used to guide public health regulations, the New York Times reports.

In Nature this week: FreeHi-C approach simulates Hi-C data from interacting genome fragments, and more.